Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

Objective: To establish safety, immunogenicity, and batch stability of a reformulated whole
cell pertussis based diphtheria‐tetanus‐whole cell pertussis (DTP) vaccine (nDTPw) …

Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

Objectives. To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-
component acellular pertussis vaccines combined with diphtheria-tetanus-acellular …

Objective: To evaluate the safety and reactogenicity of a reduced-antigen-content combined
Diphtheria-Tetanus-Acellular Pertussis (dTpa) vaccine in Indian pre-school children …

Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …

[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …

Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …

Objective: To evaluate the safety and the immunogenicity of a booster dose of recombinant
acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP, Biocine …